Shanghai, China

Yi Chen

This inventor holds 43 USPTO granted patents and 27 published patent applications and 17 EPO patents, primarily in Robotic Surgery. Top assignees: Chinese Academy of Sciences, Micron Technology Incorporated, Shanghai Haihe Pharmaceutical Co., Ltd.. Active years: 2007-2025.

USPTO Granted Patents = 43 

% Patents Active = 81.4

 

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 108(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2007)
  • Hongqiao District, CN (2013)
  • Hubei, CN (2020)
  • Shanghai, CN (2009 - 2023)
  • Guangdong, CN (2023)

Company Filing History:

goldMedal14 out of 3,341 
 
Chinese Academy of Sciences
 patents
silverMedal5 out of 39,149 
 
Micron Technology Incorporated
 patents
bronzeMedal4 out of 9 
 
Shanghai Haihe Pharmaceutical Co., Ltd.
 patents
4. 4 out of 24 
 
Shanghai Techwell Biopharmaceutical Co., Ltd.
 patents
5. 3 out of 166,264 
 
International Business Machines Corporation
 patents
6. 2 out of 2 
 
Eabmed Science and Technology (Shanghai) Co., Ltd.
 patents
7. 2 out of 56,240 
 
Intel Corporation
 patents
8. 2 out of 2,714 
 
Otis Elevator Company
 patents
9. 2 out of 6,295 
 
Sap Se
 patents
10. 2 out of 2 
 
Shanghai Kanda Biotechnology Co, Ltd.
 patents
11. 1 out of 7 
 
Cisen Pharmaceutical Co., Ltd.
 patents
12. 1 out of 72 
 
East China Normal University
 patents
13. 1 out of 1 
 
Fukang (Shanghai) Health Technology Co., Ltd.
 patent
14. 1 out of 1 
 
Haihe Biopharma Co., Ltd.
 patent
15. 1 out of 18 
 
Jiangsu Kanion Pharmaceutical Co., Ltd.
 patents
16. 1 out of 2 
 
Nanjing Luyesike Pharmaceutical Co., Ltd.
 patents
17. 1 out of 1 
 
Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
 patent
18. 1 out of 1 
 
Skyphy Networks Co., Ltd
 patent
19. 1 out of 1 
 
Skyphy Networks Communication(shanghai)
 patent
20. 5 out of 834,411 
Other
 patents
where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Robotic Arm
Minimally Invasive Surgery
Antibody Fusion Protein
Surgical Robot Control
Memory Systems
Data Organization
Compound Inhibitors
Biotechnology
Data Replication
Pharmaceutical Composition
Peptide Antibiotics
43 patents (USPTO):Explore Patents

Title: Innovations of Yi Chen: A Prolific Inventor from Shanghai

Introduction

Yi Chen, an accomplished inventor based in Shanghai, China, holds an impressive portfolio of 38 patents. His work spans across various fields, showcasing his innovative spirit and dedication to advancing technology.

Latest Patents

Among Yi Chen's notable contributions are two of his latest patents. The first patent is an "Interaction terminal and system for elevator," which presents an elevator interactive terminal integrated with a social communication media module. This inventive system enables interactive communication between users and elevators, enhancing the user experience through technology. The second patent involves "Indolizine compounds, preparation method and use thereof." This invention pertains to indolizine compounds that exhibit an inhibitory effect on EZH2 or EZH1, with potential uses as novel drugs for anti-tumor treatments or autoimmune diseases.

Career Highlights

Yi Chen has built an impressive career, having worked with prestigious organizations such as the Shanghai Institute of Materia Medica and the Chinese Academy of Sciences. Additionally, he has been associated with Micron Technology Incorporated, where his expertise has contributed to the company’s advancements in technology.

Collaborations

Throughout his career, Yi Chen has had the opportunity to collaborate with esteemed colleagues, including Jian Ding and Chunhao Yang. These partnerships have fostered an environment of creativity and innovation, leading to successful developments and patents.

Conclusion

Yi Chen’s contributions to the field of innovation, with a focus on technology and pharmaceuticals, underscore his role as a leading inventor from Shanghai. His patents not only reflect his ingenuity but also have the potential to impact various industries positively. As he continues to push the boundaries of innovation, the relevance of his work will undoubtedly persist in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…